Table 4 Detailed summary of adverse events and serious adverse events* as reported after exposure to SLD PQ together with AL
Sex | Age (years) | Baseline Hb (g/dL) | Follow-up Hb (g/dL) | Adverse event | Severity grade | Actions taken | Outcome |
|---|---|---|---|---|---|---|---|
Male | 32 | 14.9 | 13.2 | Dark urine | Moderate | Urinalysis and CBC | Recovered |
Male | 28 | 15.7 | 15.8 | Dark urine | Moderate | None | Recovered |
Female | 63 | 12.6 | 9.6 | Unwell (worsening post-dose) | Moderate | None | Unknown |
Female | 18 | 9.2 | – | Anaemia, back pain, fever, and vomiting after meals | Moderate | Prescribed drug | Recovered |
*Female | 31 | 14.1 | 12.5 | Diarrhoea, vomiting, headache, and dizziness | Moderate | Hospitalization | Recovered |
Male | 5 | 9.3 | 8.0 | Dark urine (grade: 8) | Severe | None | Recovered |
Female | 30 | 14.9 | 13.6 | Nausea | Moderate | None | Recovered |
*Male | 60 | 12.8 | – | Fever, chills, diarrhoea and vomiting | N/A | Prescribed drug | Fatal |
Male | 44 | 9.8 | 11.2 | Dark urine (grade: 5) | Mild | None | Recovered |
*Malea | 28 | 19.5 | – | Weak, jaundice, coughing | N/A | Prescribed drug | Fatal |
Female | 3 | 10.5 | 11.6 | Stomach cramps | Mild | Unknown | Recovered |